Related Experiment Video

Updated: Aug 10, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Diagnosis and management of paediatric hepatitis C virus infection

A M Kesson1

  • 1Department of Virology and Microbiology, The Children's Hospital at Westmead, Westmead, New SouthWales, Australia. alisonk2@chw.edu.au

Journal of Paediatrics and Child Health
|June 6, 2002
PubMed

Insights

Hepatitis C virus (HCV) infection in children is rare, with few guidelines for management. Early diagnosis and medical follow-up are crucial to prevent long-term liver damage in children.

Area of Science:

  • Pediatric infectious diseases
  • Hepatology
  • Virology

Background:

  • Hepatitis C virus (HCV) infection is uncommon in pediatric populations.
  • Limited clinical guidelines exist for managing HCV in children.
  • Vertical transmission of HCV occurs, with an estimated 125-250 cases annually in Australia.

Purpose of the Study:

  • To highlight the diagnostic and management challenges of pediatric Hepatitis C virus (HCV) infection.
  • To emphasize the need for improved medical surveillance and care for vertically infected children.
  • To underscore the risks associated with undiagnosed HCV in childhood, including future liver pathology.

Main Methods:

  • This study is a review of current literature and clinical guidelines regarding pediatric HCV.
  • Analysis of estimated incidence rates of vertical HCV transmission in Australia.
  • Assessment of the long-term health risks for children with undiagnosed HCV.

Main Results:

  • A significant number of children are infected vertically with HCV annually in Australia.
  • A small proportion of these children receive timely diagnosis and medical follow-up.
  • Undiagnosed HCV infection in childhood poses risks for developing severe liver disease later in life.

Conclusions:

  • There is a critical need for enhanced diagnostic strategies and management protocols for pediatric HCV.
  • Consistent medical follow-up is essential for children with HCV to ensure optimal health outcomes.
  • Proactive management can mitigate the risk of severe liver pathology and long-term sequelae in adulthood.

More Related Videos

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...